Pliant Therapeutics, Inc.

NASDAQ:PLRX

1.73 (USD) • At close September 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q12018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 86.8291.93671.18879.61680.386114.29763.23457.67954.951102.52733.68544.61725.0732.54551.66545.23135.19350.81950.88255.224178.461113.36885.80722.558-4.251
Short Term Investments 176.053213.709284.536324.897356.221368.092431.011465.933500.208474.787297.502315.624138.527145.735148.931175.813208.788213.281226.012238.776134.00728.06316.96627.1628.502
Cash and Short Term Investments 262.873305.645355.724404.513436.607482.389494.245523.612555.159577.314331.187360.241163.597178.28200.596221.044243.981264.1276.894294312.468141.431102.77349.724.251
Net Receivables 1.5351.6832.3022.2172.8032.3152.9972.1224.0224.7573.1442.3175.3921.3322.4661.6931.9132.2579.3627.2143.68232.0237.38500
Inventory 00000007.9336.2915.73803.24.325000000000000
Other Current Assets 3.0363.8634.2383.3018.1435.1948.260.6686.526.1567.1413.4074.5373.9276.8475.8474.8254.184.4986.5158.1732.6251.7421.0840
Total Current Assets 267.444311.191362.264410.031447.553489.898505.502534.335565.701588.227340.311365.965173.526185.363209.441228.584250.719270.537290.754307.729324.323176.079111.950.8044.251
Non-Current Assets:
Property, Plant & Equipment, Net 30.50731.6732.76833.72534.25829.8334.7785.7378.5189.019.90810.81810.1810.82410.9364.7064.3674.2664.3214.1444.0294.2014.0794.4230
Goodwill 0000000000000000000000000
Intangible Assets 0000000000000000000000000
Goodwill and Intangible Assets 0000000000000000000000000
Long Term Investments 1.4820001.4821.4821.482000000000000000000
Tax Assets 0000000000000000000000000
Other Non-Current Assets 0.3911.9091.9171.9090.4370.3920.3920.3920.6720.6440.3940.3970.9130.8350.8380.8310.630.4510.4510.4510.4513.7773.0850.751-4.251
Total Non-Current Assets 32.3833.57934.68535.63436.17731.7076.6526.1299.199.65410.30211.21511.09311.65911.7745.5374.9974.7174.7724.5954.487.9787.1645.174-4.251
Total Assets 299.824344.77396.949445.665483.73521.605512.154540.464574.891597.881350.613377.181184.619197.022221.215234.121255.716275.254295.526312.324328.803184.057119.06455.9780
Liabilities & Equity:
Current Liabilities:
Account Payables 1.3845.6225.966.893.2477.3274.5313.362.311.4191.583.2063.1164.6842.9712.6052.7642.8862.0233.142.4832.5321.254.4740
Short Term Debt 1.2250.7710.5420.6440.1961.5462.6364.1224.4644.764.9145.2982.0423.9983.7380000000000
Tax Payables 0000000000000000000000000
Deferred Revenue 00000-0.773000000-2.04201.8690000000000
Other Current Liabilities 17.98221.8126.71632.41827.48122.29121.35719.91322.74616.97417.41917.65717.3959.62710.12210.328.1687.3649.5767.8869.5537.0326.9223.7260
Total Current Liabilities 20.59128.20333.21839.95230.92430.39128.52427.39529.5223.15323.91326.16122.55318.30916.83112.92510.93210.2511.59911.02612.0369.5648.1728.20
Non-Current Liabilities:
Long Term Debt 28.79159.40359.6559.89160.12853.88210.05410.02112.30612.80813.35814.02614.2784.925.32500.243000.3840.4040.4250.88800
Deferred Revenue Non-Current 0000000000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000000000
Other Non-Current Liabilities 30.36000000000000000.7560.5610.8350.8660.5680.5470.506110.43900
Total Non-Current Liabilities 59.15159.40359.6559.89160.12853.88210.05410.02112.30612.80813.35814.02614.2784.925.3250.7560.8040.8350.8660.9520.9510.931111.32700
Total Liabilities 79.74287.60692.86899.84391.05284.27338.57837.41641.82635.96137.27140.18736.83123.22922.15613.68111.73611.08512.46511.97812.98710.495119.4998.20
Equity:
Preferred Stock 0000000000000000000312.324328.803238.31375.86133.44739.91
Common Stock 0.0060.0060.0060.0060.0060.0060.0060.0060.0060.0060.0050.0050.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.0010.0010
Retained Earnings -809.518-766.218-710.052-660.32-602.557-546.703-499.748-458.639-417.152-375.96-338.412-303.352-272.737-243.191-215.091-190.56-163.515-140.684-117.828-98.801-82.267-65.266-76.295-86.5170
Accumulated Other Comprehensive Income/Loss -0.0010.1590.3210.848-0.617-0.4890.345-1.907-2.241-1.331-1.958-2.454-1.259-0.95-0.201-0.04-0.03-0.018-0.032-0.018-0.030.059-0.0010.003-36.565
Other Total Stockholders Equity 1,029.5951,023.2171,013.8061,005.288995.846984.518972.973963.588952.452939.205653.707642.795421.781417.931414.348411.037407.522404.868400.918399.162398.110.455000
Total Shareholders Equity 220.082257.164304.081345.822392.678437.332473.576503.048533.065561.92313.342336.994147.788173.793199.059220.44243.98264.169283.061300.346315.816173.562-0.43546.9343.345
Total Equity 220.082257.164304.081345.822392.678437.332473.576503.048533.065561.92313.342336.994147.788173.793199.059220.44243.98264.169283.061300.346315.816173.562-0.43546.9343.345
Total Liabilities & Shareholders Equity 299.824344.77396.949445.665483.73521.605512.154540.464574.891597.881350.613377.181184.619197.022221.215234.121255.716275.254295.526312.324328.803184.057119.06455.1343.345